Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice

Archive ouverte

Noll, Christophe | Dairou, Julien | Ripoll, Clémentine | Paul, Jean-Louis | Dupret, Jean-Marie | Delabar, Jean-Maurice | Rodrigues-Lima, Fernando | Janel, Nathalie

Edité par CCSD ; Elsevier -

International audience. Hyperhomocysteinemia leads to diverse clinical manifestations, notably liver disease. The pathogenicity of homocysteine is believed to be due to its ability to produce oxidative stress. Paraoxonase-1 (Pon1), a phase I xenobiotic-metabolizing enzyme (XME) synthesized by liver with anti-oxidative properties within the circulating system is down regulated in case of hyperhomocysteinemia. In a previous study, we have shown that red wine polyphenol extract (PE) supplementation induces a decrease in plasma homocysteine level and an increase in hepatic Pon1 gene expression concomitant with an increase in hepatic and plasma Pon1 activity in a murine model of hyperhomocysteinemia. In the present study, we analyzed the effect of PE supplementation on two phase II XME: NAD(P)H:quinone oxidoreductase (Nqo1) and arylamine-N-acetyltransferase (Nat) family. We found that hyperhomocysteinemia leads to a decrease of hepatic Nqo1 gene expression and activity with a reversal effect of PE supplementation. We also found that hyperhomocysteinemia-induced decrease of peroxynitrite level is associated with an increase of hepatic total Nat activity mainly due to the Nat2 isoform with a reversal effect of PE supplementation. Our results show a beneficial effect of PE supplementation on two phase II enzymes which are altered in case of hyperhomocysteinemia. (C) 2011 Elsevier Ltd. All rights reserved.

Consulter en ligne

Suggestions

Du même auteur

Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism

Archive ouverte | Noll, Christophe | CCSD

International audience. Background and aims: Among cardiovascular risk factor, people with Down syndrome have a lower plasma homocysteine level. In a previous study, we have shown that DYRK1A (dual-specificity tyros...

Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice

Archive ouverte | Noll, Christophe | CCSD

International audience. Hyperhomocysteinemia leads to several clinical manifestations and, particularly, liver disease. Lowering homocysteine through nutrition or other means might offer preventive or therapeutic be...

Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice

Archive ouverte | Abekhoukh, Sabiha | CCSD

International audience. Hyperhomocysteinemia due to cystathionine beta synthase (CBS) deficiency is associated with diverse brain disease. Whereas the biological actions linking hyperhomocysteinemia to the cognitive...

Chargement des enrichissements...